| 4ENH | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | FVX, HEM | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | In Silico and Intuitive Predictions of CYP46A1 Inhibition by Marketed Drugs with Subsequent Enzyme Crystallization in Complex with Fluvoxamine., Mast N, Linger M, Clark M, Wiseman J, Stout CD, Pikuleva IA, Mol Pharmacol. 2012 Aug 2. PMID:22859721 | ||||||||||||||
| Data retrieval |
![]() |
| View 4ENH in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |